Prepared by R.R. Donnelley Financial -- Form 8-K
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
September 5, 2002
NEOTHERAPEUTICS, INC.
(Exact Name of Registrant as Specified in Charter)
| Delaware
|
|
000-28782
|
|
93-0979187
|
| (State or Other Jurisdiction of Incorporation) |
|
(Commission File Number)
|
|
(I.R.S. Employer Identification
No.) |
157 Technology Drive
Irvine, California 92618
(Address of Principal Executive Offices)
(949) 788-6700
(Registrant’s telephone number, including area code)
ITEM 5. OTHER EVENTS
On September 5, 2002, NeoTherapeutics, Inc. (the “Company”) issued a press release announcing that its stockholders have approved an amendment to the Company’s certificate of
incorporation to effect a 25-for-1 reverse split of the Company’s common stock. The stockholders of the Company also approved the raising, as necessary, of up to $10,000,000, through the issuance of the Company’s common stock and/or
warrants exercisable for the purchase of common stock, up to a maximum of 10,000,000 shares of common stock, potentially at discounts to the then current market price.
The text of the press release is set forth in Exhibit 99.1 attached to this report and incorporated herein by this reference.
ITEM 7. EXHIBITS
| Exhibits:
|
|
|
| 99.1 |
|
Press release dated September 5, 2002. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: September 6, 2002 |
|
|
|
NEOTHERAPEUTICS, INC. |
| |
| |
|
|
|
|
|
By: |
|
/s/ RAJESH
SHROTRIYA
|
| |
|
|
|
|
|
Name: |
|
Rajesh Shrotriya, M.D. |
| |
|
|
|
|
|
Title: |
|
Chairman of the Board, Chief Executive Officer and President |
3
EXHIBIT INDEX
| Exhibits:
|
|
|
| 99.1 |
|
Press release dated September 5, 2002. |
4